# Investigating the Morbidity of Glucocorticoid Use in Patients With Autoimmune Bullous Diseases (AIBDs)

> **NCT05525065** · — · UNKNOWN · sponsor: **Premier Specialists, Australia** · enrollment: 138 (estimated)

## Conditions studied

- Autoimmune Bullous Dermatosis
- Glucocorticoids Toxicity

## Interventions

- **DRUG:** GlucoCorticoid

## Key facts

- **NCT ID:** NCT05525065
- **Lead sponsor:** Premier Specialists, Australia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-02
- **Primary completion:** 2023-09-01
- **Final completion:** 2025-09-01
- **Target enrollment:** 138 (ESTIMATED)
- **Last updated:** 2023-08-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05525065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05525065, "Investigating the Morbidity of Glucocorticoid Use in Patients With Autoimmune Bullous Diseases (AIBDs)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05525065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*